Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions
The entorhinal–hippocampal circuit is severely affected in Alzheimer's disease (AD). Here, we demonstrate that amyloid-β (Aβ) differentially affects primary cultured astrocytes derived from the entorhinal cortex (EC) and from the hippocampus from non-transgenic controls and 3xTg-AD transgenic m...
Main Authors: | Grolla, A A, Sim, J A, Lim, D, Rodriguez, J J, Genazzani, A A, Verkhratsky, A |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674354/ |
Similar Items
-
Calcium-Sensing Receptors of Human Astrocyte-Neuron Teams: Amyloid-β-Driven Mediators and Therapeutic Targets of Alzheimer’s Disease
by: Dal Prà, I, et al.
Published: (2014) -
Antagonizing amyloid-β/calcium-sensing receptor signaling in human astrocytes and neurons: a key to halt Alzheimer's disease progression?
by: Dal Prà, Ilaria, et al.
Published: (2015) -
Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
by: Batarseh, Yazan S., et al.
Published: (2016) -
Pathological Role for Exocytotic Glutamate Release from Astrocytes in Hepatic Encephalopathy
by: Montana, Vedrana, et al.
Published: (2014) -
Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease
by: Yeh, Chia-Yu, et al.
Published: (2011)